돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1669961생성일: 2026년 10월 25일

2,5-Dichloronitrobenzene → Escitalopram

https://huagongshe.com/reaction/1669961

반응식

참여 물질

역할이름HCID투입량
반응물2,5-DichloronitrobenzeneHCID 6977—
반응물Oxalic acid dihydrateHCID 61373—
반응물Citadiol, (S)-HCID 7472057—
반응물Potassium tert-butoxideHCID 23665647—
용매AcetoneHCID 180—
용매WaterHCID 962—
용매TetrahydrofuranHCID 8028—
생성물EscitalopramHCID 146570—
생성물Escitalopram OxalateHCID 146571—

반응 단계

To a solution of 6 gm of (S)-(−)-4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxy-1-butyl]-3-(hydroxymethyl)benzonitrile in 60 ml tetrahydrofuran (THF) was added 4.33 gm of potassium tertiary butoxide at 0-10° C. and stirred for 30 minutes. A solution of 4.04 gm of 2,5-dichloronitrobenzene in 30 ml THF at 0-10° C. was added to it and stirred for 10-15 hours at room temperature, followed by addition of 250 ml of water. The reaction mixture was extracted with toluene, the toluene layer was washed with water and 5% sodium hydroxide solution and after acid base treatment yielded an oily product. The oil was dissolved in 16 ml of acetone at 30° C. and 1.75 gm of oxalic acid dihydrate in 8 ml acetone was added to it, stirred, cooled, filtered and dried at 60° C. to get the oxalic acid salt of (S)-(+)-1-[3-(dimethylamino) propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07989645B2
출처 데이터셋uspto-grants-2011_08
ORD IDord-6c65327698f545e2aa4c6b9ca64f2185
출처 메모uspto-grants-2011_08